Elevance Health (NYSE: ELV) CEO Gail Boudreaux purchases 2,725 shares
Rhea-AI Filing Summary
Elevance Health, Inc. President and CEO Gail Boudreaux reported purchases of a total of 2,725 shares of common stock on July 17, 2026. She bought 680 shares at a weighted-average price of $366.41 (with trade prices from $366.14 to $366.48) and 2,045 shares at a weighted-average price of $368.25 (with trade prices from $367.76 to $368.69). After these transactions, she directly holds 171,976 shares and indirectly holds 60 shares through her spouse’s revocable trust. The Rule 10b5-1 trading plan checkbox was not marked for these transactions.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 2,725 shares ($1,002,230)
Net Buy
3 txns
Insider
BOUDREAUX GAIL
Role
President and CEO
Bought
2,725 shs ($1.00M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 680 | $366.41 | $249K |
| Purchase | Common Stock | 2,045 | $368.25 | $753K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 169,931 shares (Direct);
Common Stock — 60 shares (Indirect, Shares Held in Spouse's Revocable Trust)
Footnotes (1)
- This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Total shares purchased: 2,725 shares
First tranche average price: $366.41 per share
Second tranche average price: $368.25 per share
+2 more
5 metrics
Total shares purchased
2,725 shares
Common stock bought by Gail Boudreaux on July 17, 2026
First tranche average price
$366.41 per share
680 shares purchased; trade prices ranged from $366.14 to $366.48
Second tranche average price
$368.25 per share
2,045 shares purchased; trade prices ranged from $367.76 to $368.69
Direct holdings after transactions
171,976 shares
Directly held Elevance Health common stock following July 17, 2026 purchases
Indirect holdings via revocable trust
60 shares
Shares held in spouse's revocable trust reported as indirect ownership
Key Terms
revocable trust, weighted average purchase price, indirect ownership, open market or private transaction
4 terms
revocable trust financial
"Shares held in spouse's revocable trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
weighted average purchase price financial
"The price reported reflects the weighted average purchase price"
The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.
indirect ownership financial
"ownership_type reported as indirect through spouse's revocable trust"
open market or private transaction financial
"Purchase in open market or private transaction"
AI-generated analysis. How Rhea-AI works. Not financial advice.
